Editorial: proton pump inhibitor use in cirrhosis-a piece of the puzzle

Ciro Celsa^{1

2}, Calogero Cammà¹

Affiliations

¹ Section of Gastroenterology & Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, Palermo, Italy.
² Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, Palermo, Italy.

Editorial

Ciro Celsa et al. Aliment Pharmacol Ther. 2021 Mar.

. 2021 Mar;53(5):663-664.

doi: 10.1111/apt.16250.

Ciro Celsa^{1

2}, Calogero Cammà¹

¹ Section of Gastroenterology & Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, Palermo, Italy.
² Department of Surgical, Oncological and Oral Sciences (Di.Chir.On.S.), University of Palermo, Palermo, Italy.

No abstract available

Comment in

Editorial: proton pump inhibitor use in cirrhosis-a piece of the puzzle. Authors' reply.
Rocco A, Compare D, Sgamato C, Coccoli P, Nardone G. Rocco A, et al. Aliment Pharmacol Ther. 2021 Mar;53(5):665-666. doi: 10.1111/apt.16254. Aliment Pharmacol Ther. 2021. PMID: 33566407 No abstract available.

Impact of proton pump inhibitors on cytochrome P450 activity assessed by ¹³ C-aminopyrine breath test in patients with cirrhosis.
Rocco A, Compare D, Sgamato C, Coccoli P, Chiodini P, Nardone G. Rocco A, et al. Aliment Pharmacol Ther. 2021 Mar;53(5):608-615. doi: 10.1111/apt.16239. Epub 2020 Dec 28. Aliment Pharmacol Ther. 2021. PMID: 33368499 Clinical Trial.

1. Lewis JH, Stine JG. Review article: prescribing medications in patients with cirrhosis - a practical guide. Aliment Pharmacol Ther. 2013;37:1132-1156.
1. Shin JM, Kim N. Pharmacokinetics and pharmacodynamics of the proton pump inhibitors. J Neurogastroenterol Motil. 2013;19:25-35.
1. Weersink RA, Taxis K, Drenth JPH, Houben E, Metselaar HJ, Borgsteede SD. Prevalence of drug prescriptions and potential safety in patients with cirrhosis: a retrospective real-world study. Drug Saf. 2019;42:539-546.
1. Trifan A, Stanciu C, Girleanu I, et al. Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol. 2017;23:6500-6515.
1. Bajaj JS, Ratliff SM, Heuman DM, et al. Proton pump inhibitors are associated with a high rate of serious infection in veterans with decompensated cirrhosis. Aliment Pharmacol Ther. 2012;36:866-874.